T-cell receptor (TCR) recognizing influenza viral epitope (TCR)

T-cell receptors (TCRs) recognizing processed influenza viral epitopes are specialized heterodimeric surface proteins, typically composed of alpha and beta chains, that are central to the adaptive cellular immune response against influenza A and B viruses [UniProt]. These receptors specifically recognize viral peptides, such as the highly conserved Matrix protein 1 (M1) epitope (GILGFVFTL), when they are processed and presented by Major Histocompatibility Complex (MHC) class I molecules on the surface of infected cells [PubMed, PMID: 25108026]. Upon binding to the peptide-MHC complex, the TCR initiates an intracellular signaling cascade involving the CD3 complex and kinases like ZAP-70, which leads to T-cell proliferation, the secretion of pro-inflammatory cytokines such as IFN-gamma, and the direct lysis of infected respiratory epithelial cells [StatPearls]. In the pharmaceutical landscape, these TCRs are utilized as the basis for adoptive T-cell therapies (TCR-T), where a patient's T cells are engineered to express high-affinity receptors targeting conserved viral antigens to provide broad-spectrum protection [NIH]. They are also the focus of universal vaccine strategies designed to elicit robust T-cell memory that can recognize multiple influenza strains, including pandemic variants. However, therapeutic application faces significant challenges, including the high degree of HLA polymorphism in the human population, which restricts the use of specific TCRs to patients with matching MHC alleles, and the risk of off-target toxicity if the engineered TCR cross-reacts with similar self-antigens [Nature Reviews Immunology].

Other names

T-cell antigen receptorInfluenza-specific T-cell receptorM1-specific TCRAlpha-beta T-cell receptorpMHC-specific T-cell receptor

Recognition of influenza-derived peptides (e.g., Matrix protein 1, Nucleoprotein) presented by Major Histocompatibility Complex (MHC) molecules, triggering T-cell receptor signaling and subsequent destruction of virus-infected cells.